Palisade Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$269K Buy
+2,599
New +$232K 0.02% 184
2026
Q1
Sell
-2,602
Closed -$206K 197
2025
Q4
$206K Hold
2,602
0.02% 192
2025
Q3
$196K Sell
2,602
-497
-16% -$34.1K 0.02% 195
2025
Q2
$214K Hold
3,099
0.02% 190
2025
Q1
$210K Buy
+3,099
New +$185K 0.02% 189
2024
Q4
Sell
-3,227
Closed -$203K 195
2024
Q3
$203K Sell
3,227
-3,182
-50% -$186K 0.02% 196
2024
Q2
$379K Sell
6,409
-1,209
-16% -$75.6K 0.04% 165
2024
Q1
$608K Buy
7,618
+500
+7% +$38.2K 0.06% 140
2023
Q4
$562K Buy
7,118
+630
+10% +$44.8K 0.06% 142
2023
Q3
$453K Sell
6,488
-2,037
-24% -$144K 0.06% 145
2023
Q2
$589K Buy
8,525
+61
+0.7% +$4.34K 0.07% 135
2023
Q1
$629K Sell
8,464
-24
-0.3% -$2.01K 0.08% 132
2022
Q4
$791K Sell
8,488
-4
-0% -$386 0.09% 128
2022
Q3
$810K Sell
8,492
-74
-0.9% -$7.33K 0.11% 120
2022
Q2
$794K Sell
8,566
-24
-0.3% -$2.34K 0.1% 117
2022
Q1
$869K Sell
8,590
-66
-0.8% -$6.93K 0.1% 117
2021
Q4
$893K Buy
8,656
+66
+0.8% +$6.1K 0.1% 116
2021
Q3
$729K Buy
8,590
+1,322
+18% +$111K 0.09% 120
2021
Q2
$606K Sell
7,268
-24
-0.3% -$1.97K 0.07% 134
2021
Q1
$549K Buy
7,292
+560
+8% +$40.8K 0.07% 135
2020
Q4
$460K Sell
6,732
-860
-11% -$55.9K 0.06% 145
2020
Q3
$443K Sell
7,592
-2,500
-25% -$156K 0.07% 135
2020
Q2
$656K Sell
10,092
-4,580
-31% -$288K 0.1% 112
2020
Q1
$870K Sell
14,672
-1,313
-8% -$87.7K 0.16% 96
2019
Q4
$1.19M Buy
15,985
+213
+1% +$15K 0.17% 94
2019
Q3
$995K Sell
15,772
-150
-0.9% -$8.89K 0.15% 102
2019
Q2
$868K Hold
15,922
0.13% 107
2019
Q1
$859K Buy
15,922
+9,000
+130% +$555K 0.14% 109
2018
Q4
$454K Buy
6,922
+125
+2% +$9.33K 0.07% 121
2018
Q3
$535K Hold
6,797
0.07% 122
2018
Q2
$437K Buy
6,797
+500
+8% +$33K 0.06% 127
2018
Q1
$392K Hold
6,297
0.06% 133
2017
Q4
$457K Sell
6,297
-400
-6% -$29.1K 0.07% 128
2017
Q3
$545K Buy
6,697
+1,000
+18% +$79.1K 0.1% 105
2017
Q2
$458K Hold
5,697
0.09% 104
2017
Q1
$447K Buy
5,697
+300
+6% +$23.9K 0.08% 105
2016
Q4
$426K Sell
5,397
-850
-14% -$68.8K 0.08% 107
2016
Q3
$556K Hold
6,247
0.1% 95
2016
Q2
$598K Sell
6,247
-420
-6% -$41.9K 0.11% 93
2016
Q1
$692K Buy
6,667
+870
+15% +$84.6K 0.13% 88
2015
Q4
$567K Sell
5,797
-330
-5% -$32.3K 0.12% 93
2015
Q3
$591K Sell
6,127
-50
-0.8% -$5.26K 0.13% 95
2015
Q2
$648K Sell
6,177
-520
-8% -$53.1K 0.13% 95
2015
Q1
$691K Buy
6,697
+840
+14% +$85K 0.14% 94
2014
Q4
$564K Sell
5,857
-400
-6% -$35.2K 0.11% 94
2014
Q3
$498K Hold
6,257
0.1% 99
2014
Q2
$472K Hold
6,257
0.1% 97
2014
Q1
$468K Hold
6,257
0.1% 97
2013
Q4
$448K Hold
6,257
0.1% 98
2013
Q3
$355K Sell
6,257
-1,615
-21% -$96.2K 0.09% 101
2013
Q2
$450K Buy
+7,872
New +$456K 0.11% 95

Other funds holding CVS

Palisade Asset Management's CVS Position: Q2 2026 in Review

Palisade Asset Management opened a new position in CVS Health (CVS) in Q2 2026: 2,599 shares worth $269K. The stake represents 0.02% of the portfolio and ranks #184 among its holdings. This is a return to the name: Palisade Asset Management previously reported a position in CVS as recently as Q4 2025.

Palisade Asset Management first reported a position in CVS in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.19M in Q4 2019. 567 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Palisade Asset Management held 2,599 shares of CVS Health worth $269K as of Q2 2026.
  • CVS Health was a new Palisade Asset Management position in Q2 2026.
  • CVS Health made up 0.02% of Palisade Asset Management's portfolio in Q2 2026, its #184 holding.
  • Palisade Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 51 quarters since.
  • Palisade Asset Management's CVS Health position peaked at $1.19M in Q4 2019.
  • 567 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Palisade Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.